Early interferon therapy may mitigate COVID-19 severity

The coronavirus disease 2019 (COVID-19) pandemic has now spread for over 10 months, evading capture by effective antivirals. The earliest vaccines are still in phase III of their clinical trials. Remdesivir is among the very few drugs that show even moderate benefit in this illness. A recent review of COVID-19 therapies published in the journal [...]

Published November 26, 2020 at 10:24AM. Read full article at Stem Cells in the News Portal.